Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Key Statistics & Financial Ratios

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) — Price $3.13 HealthcareDrug Manufacturers - Specialty & Generic — NASDAQ

Latest reported results:

Key statistics dashboard for Shuttle Pharmaceuticals Holdings, Inc. (SHPH). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Stock Data

Price$3.13
Market Cap$2M
Enterprise Value$955521
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio-0.05
Price / Book0.47
P/S0.00
EV/EBITDA-0.10
EV/Sales0.00
EV/FCF-0.10
P/FCF-0.20
Earnings Yield-687.11%
FCF Yield-511.73%
Dividend Yield0.00%

Profitability

Gross Margin0.00%
EBIT Margin0.00%
EBITDA Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity-408.33%
Return on Assets-91.63%
Return on Invested Capital-312.04%
Return on Capital Employed-319.16%

Financial Health

Current Ratio0.30
Quick Ratio0.30
Cash Ratio0.13
Debt / Equity0.06
Debt / Assets1.81%
Net Debt / EBITDA0.09
Interest Coverage-157.45
Piotroski F-Score3
Altman Z-Score-10.78

Per-Share Data

Revenue per share0.00
Book Value per share6.65
Cash per share2.17
FCF per share-18.63
Tangible Book Value per share-11.72
Dividend per share0.00

Related companies: AKAN · BBLG · BIVI · HSCS · IMCC · ISPC · MSPR

Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic

More sections of SHPH: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks